GlassScriptPhysician profile
Tasha Joseph
NPI 1467140046
$5,270.42
in general payments reported to CMS, 2019-2025
23 companies · $3,217 in 2025
The $3,217 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.27 · 2024: $2,036 · 2025: $3,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,809 · Education: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,809.45 |
| Education | $460.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $811.56 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $676.33 | 2024-2025 | Xtandi, Veozah |
| Janssen Biotech, INC. | $545.80 | 2024-2025 | Erleada, Carvykti, Rybrevant |
| Dendreon Pharmaceuticals LLC | $409.39 | 2024-2025 | Provenge |
| Telix Pharmaceuticals | $389.62 | 2024-2025 | Illuccix |
| Urogen Pharma, INC. | $357.99 | 2024-2025 | |
| Boston Scientific Corporation | $343.62 | 2024-2025 | Axonics, Moses, Rezum Generator |
| Blue Earth Diagnostics | $337.50 | 2024-2025 | Posluma |
| Antares Pharma, INC. | $197.21 | 2024-2025 | Xyosted |
| Pfizer INC. | $188.06 | 2024-2025 | |
| Accord Healthcare, INC. | $184.35 | 2024-2025 | |
| Medtronic, INC. | $164.77 | 2024 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $141.88 | 2025 | |
| Endo USA, INC. | $94.25 | 2025 | Xiaflex, Aveed |
| 180 Medical, INC. | $92.25 | 2025 | Gentlecath Glide |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $81.69 | 2024-2025 | Prolaris |
| Novartis Pharmaceuticals Corporation | $81.57 | 2025 | |
| Ferring Pharmaceuticals INC. | $40.37 | 2024 | Adstiladrin |
| Immunitybio, INC. | $37.91 | 2025 | |
| Axonics, INC. | $33.79 | 2024 | Axonics, Bulkamid |
| Teleflex LLC | $22.27 | 2025 | Barrigel |
| Abbvie INC. | $21.60 | 2025 | |
| Abc Home Medical Supply, INC. | $16.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tasha Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.